Reuters logo
BRIEF-Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent
January 5, 2017 / 9:40 PM / 9 months ago

BRIEF-Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent

Jan 5 (Reuters) - Cerveau Technologies Inc:

* Cerveau Technologies, Inc signs license agreement with Merck for novel investigational tau imaging agent

* Cerveau Technologies Inc - responsible for clinical development, commercialization of mk-6240 for license fees, milestone payments and royalties Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below